The MTHFR gene has been reported as a susceptibility locus for sporadic Parkinson's disease (sPD 
Introduction
Parkinson's disease (PD) is a multifactorial neuro degenerative disease that affects about 12% of peo ple older than 65 years [23] , sporadic cases (sPD) being more frequent than familial ones. Among genetic factors influencing PD, rare variants in PARK genes such as LRRK2 (PARK8) and SNCA (PARK1) [2, 5] are known to play a major role in PD pathogenesis (rare variant common disease hypothesis) [3, 14] . However, it is possible that common variants in other genes account for part of the unrevealed heritability of PD (the common variant common disease hypoth esis) [16] . In this regard, the MTHFR gene has been
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The rs1801133 variant is associated with Parkinson's disease recently proposed as a candidate risk gene for PD by two independent metaanalyses [24, 25] .
The enzyme MTHFR (EC 1.5.1.20) catalyzes the transformation of 5,10methylenetetrahydrofolate to 5methyltetrahydrofolate, a cosubstrate for ho mo cysteine remethylation to methionine. The T allele of the functional rs1801133 variant in this gene gen erates a thermolabile enzyme with reduced activity. The homozygous state of this variant (TT) has been linked to elevated plasma homocysteine (Hcy) levels [9] , although optimal folate and vitamin B 12 intake can counteract the effect of genotype [12] . Elevat ed Hcy may hasten dopaminergic cell death through oxidative stress and excitotoxicity [7, 18] .
Variants in the MTHFR gene may also influence the response to treatment, since impaired trans methylation potential has been detected in hyper homocysteinemic Ldopatreated PD patients [6] .
Among different populations, MexicanMestizos (most presentday Mexicans) have the highest fre quency of the T allele [20] ; therefore we sought to determine whether rs1801133 is associated with SPD in our population.
Material and methods

Patients and controls
We conducted a casecontrol study that included 140 SPD patients and 216 neurologically healthy con trols. Institutional Committees approved the study and informed written consent was obtained from participants. Patients were recruited from February 2009 to June 2010, from four tertiarycare level hos pitals in Mexico (Neurology Departments from Cen tro Médico Nacional "20 de Noviembre" -ISSSTE, Centro Médico Nacional Siglo XXIIMSS, Instituto de Ciencias Médicas y de la Nutrición "Salvador Zubirán", Mexico City; and División de Genética, Centro de Investigación Biomédica de Occidente IMSS, Jalisco, Mexico). Diagnosis was performed according to Queen Square Brain Bank criteria [15] .
The threshold for earlyonset Parkinson's disease (EOPD) was considered as onset earlier than 40 years old. Cognitive impairment was assessed using the Folstein Mini Mental State Examination Test. We did not measure plasma Hcy levels because most PD patients could show elevated levels derived from pharmacological therapy with Ldopa. Controls were healthy blood bank donors or patients' spouses who agreed to participate in an additional neurological evaluation; they were MexicanMestizos without family history of neurodegenerative disorders.
DNA isolation and genotyping
DNA was extracted from peripheral blood sam ples by the DTAB CTAB method [13] . Genotyping was performed by realtime PCR using TaqMan probes (Hydrolysis probes) using the C_1202883_20 assay (Applied Biosystems, Foster City, CA, USA). Realtime PCR was performed on a LightCycler 480 II (Roche Diagnostics GmbH, Switzerland); PCR reactions were conducted according to the manufacturer's instruc tions. Random samples were confirmed by high resolution melting curves (Fig. 1) . The samples were previously screened for common variants in six PARK genes, including A30P of SNCA and G2019S and G2385R of LRRK2; the prevalence of DNA changes was low [10] .
Statistical analysis
Statistical analysis was performed using SPSS software v. 18.0 (SPSS Inc., Chicago, IL, USA) for the χ 2 test, logistic regression and ANOVA. HardyWein berg equilibrium (HWE) was estimated in both groups using the χ 2 test (http://ihg.gsf.de/cgibin/hw/hwa1. pl [20/08/2013] Table I . The association test showed that the C allele was associated with PD only under the recessive mod el (OR = 2.02, CI: 1.083.77, p = 0.02); after logistic regression for known confounding factors, the asso ciation remained significant (exp(β) = 2.06, CI: 1.101 3.873, p = 0.024). There was no association of any allele and cognitive impairment (p = 0.33). Oneway ANOVA showed no differences between genotypes and age at onset (p > 0.05). Additionally, when age at onset was categorized (EOPD), the χ 2 test did not show an association of any allele or genotype and EOPD (p > 0.05) (TT group n = 31).
Discussion
In contrast to the hypothesis that the TT geno type of rs1801133 in the MTHFR gene leads to ele vated levels of Hcy, cell death and therefore a higher risk of neurodegeneration [25] , our data suggest that the CC genotype is associated with PD. This may be explained by the fact that the TT genotype has the greatest influence on Hcy levels in populations with low folate and high B 12 vitamin plasma concentra tion such as Africans but not MexicanMestizos, in whom folate and B 12 levels were high and moder ate respectively [11] . Thus the TT genotype does not always imply high Hcy levels; in fact, a protective effect of the TT genotype against preeclampsia was reported in MayaMestizo women [1] .
Others have also suggested that homozygosis of the T allele may confer a survival advantage in pop ulations with sufficient dietary folate consumption [11, 17, 19] . Therefore, it is expected that in some pop ulations such as MexicanMestizos, the T allele even when linked to an impaired biochemical function (elevated Hcy) may represent the wildtype allele, since an advantage may fix an allele within a pop ulation under particular environmental conditions. A presumptive advantage may exist, as described previously in an intervention where folate sources and dosages where controlled [4] . In contrast to its counterpart, the TT genotype showed only a slight decrease in global DNA methylation after folate depletion; conversely, under low folate basal levels, the TT genotype has shown significantly diminished global DNA methylation [8] . Thus, the finding that the derived CC genotype has the greatest decrease in DNA methylation after folate depletion may repre sent a different mechanism linked to neurodegenera tion, besides the known effect of hyperhomocystei nemia on neuronal cytotoxicity [4] .
The ancestral C allele may be considered the risk variant for PD in the MexicanMestizo popula tion. Although it is speculative, hypomethylation as observed with the CC genotype under folate depletion may potentially impact epigenetic regula tion of other genes such as LRRK2 and SNCA [21] . SNCA protein is also involved in the arrest of DNMT1 (a major element in epigenetic regulation) in post mortem brains of PD patients, worsening in this way the hypomethylation phenomenon [21] . Inter estingly, another study found this same genotype (CC of rs1801133) related to earlier age at onset of PD [22] . Our data do not replicate the observation, probably because in our group patients with EOPD were uncommon. Larger studies documenting age at onset and MTHFR genotype may confirm this find ing. To our knowledge this is the first report on asso ciation of the CC genotype of MTHFR and SPD. Other studies in different populations with larger samples may add support to our hypothesis in which conver gent pathways between common and rare variants may potentially affect complex neurodegenerative disorders such as PD. 
Limitations of the study
Some of the limitations of the present study were that since a considerable proportion of patients were treated with Ldopa among other antiparkinsonian drugs, homocysteine levels or global methylation were not measured and therefore the genotypephe notype correlation could not be explored to support our hypothesis. The presence of essential hyper tension could not be assessed accurately, since the study was not intended to do so. The statistical pow er reached was 72% (lower than the expected 80%).
